14 research outputs found

    Climate change impacts and adaptation in forest management: a review

    Get PDF

    Beyond reduced-impact logging: silvicultural treatments to increase growth rates of tropical trees

    No full text
    Use of reduced-impact logging (RIL) techniques has repeatedly been shown to reduce damage caused by logging. Unfortunately, these techniques do not necessarily ameliorate the low growth rates of many commercial species or otherwise assure recovery of the initial volume harvested during the next cutting cycle. In this study, we analyze the effect of logging and application of additional silvicultural treatments (liana cutting and girdling of competing trees) on the growth rates on trees in general and on of future crop trees (FCTs) of 24 commercial timber species. The study was carried out in a moist tropical forest in Bolivia, where we monitored twelve 27-ha plots for 4 years. Plots received one of four treatments in which logging intensity and silvicultural treatments were varied: control (no logging); normal (reduced-impact) logging; normal logging and low-intensity silviculture; and, increased logging intensity and high-intensity silviculture. Tree growth rates increased with intensity of logging and silvicultural treatments. The growth rates of FCTs of commercial species were 50–60% higher in plots that received silvicultural treatments than in the normal logging and control plots. Responses to silvicultural treatments varied among functional groups. The largest increase in growth rates was observed in FCTs belonging to the partially shade-tolerant and the shade-tolerant groups. These results indicate that silvicultural treatments, in addition to the use of RIL techniques, are more likely to result in a higher percentage of timber volume being recovered after the first cutting cycle than RIL alone

    Soil Effects on Forest Structure and Diversity in a Moist and a Dry Tropical Forest

    No full text
    Soil characteristics are important drivers of variation in wet tropical forest structure and diversity, but few studies have evaluated these relationships in drier forest types. Using tree and soil data from 48 and 32 1 ha plots, respectively, in a Bolivian moist and dry forest, we asked how soil conditions affect forest structure and diversity within each of the two forest types. After correcting for spatial effects, soil-vegetation relationships differed between the dry and the moist forest, being strongest in the dry forest. Furthermore, we hypothesized that soil nutrients would play a more important role in the moist forest than in the dry forest because vegetation in the moist forest is less constrained by water availability and thus can show its full potential response to soil fertility. However, contrary to our expectations, we found that soil fertility explained a larger number of forest variables in the dry forest (50 percent) than in the moist forest (17 percent). Shannon diversity declined with soil fertility at both sites, probably because the most dominant, shade-tolerant species strongly increased in abundance as soil fertility increased

    Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics

    No full text
    Background: One of the goals of the Multi-site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM) study was to evaluate whether clinicians experienced in diagnosing and caring for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) recognized the same clinical entity. Methods: We enrolled participants from seven specialty clinics in the United States. We used baseline data (n = 465) on standardized questions measuring general clinical characteristics, functional impairment, post-exertional malaise, fatigue, sleep, neurocognitive/autonomic symptoms, pain, and other symptoms to evaluate whether patient characteristics differed by clinic. Results: We found few statistically significant and no clinically significant differences between clinics in their patients’ standardized measures of ME/CFS symptoms and function. Strikingly, patients in each clinic sample and overall showed a wide distribution in all scores and measures. Conclusions: Illness heterogeneity may be an inherent feature of ME/CFS. Presenting research data in scatter plots or histograms will help clarify the challenge. Relying on case–control study designs without subgrouping or stratification of ME/CFS illness characteristics may limit the reproducibility of research findings and could obscure underlying mechanisms
    corecore